Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|December 17, 2008
Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patientsR Srirajaskanthan, C Toumpanakis, A Karpathakis, et al.
Lancet (London, England)|September 16, 1998
Carcinoid tumourM E Caplin, J R Buscombe, A J Hilson, et al.
British Journal of Cancer|April 1, 1996
Human liver cancer cells and endothelial cells incorporate iodised oilS Bhattacharya, A P Dhillon, M C Winslet, et al.
The European Respiratory Journal|August 1, 1995
Anti-tuberculosis medication and the liver: dangers and recommendations in managementN P Thompson, M E Caplin, M I Hamilton, et al.
Alimentary Pharmacology & Therapeutics|February 4, 2003
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experienceJ Garland, J R Buscombe, C Bouvier, et al.
The American Journal of Gastroenterology|October 15, 1998
Multimodality treatment for gastric carcinoid tumor with liver metastasesM E Caplin, H J Hodgson, A P Dhillon, et al.
Nuclear Medicine Communications|March 16, 2000
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumoursM E Caplin, W Mielcarek, J R Buscombe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2015
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoidsM E Caplin, E Baudin, P Ferolla, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancerT Meyer, M E Caplin, D H Palmer, et al.
Pageof 9